Table of Content

1 INTRODUCTION (Page No. - 23)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SEGMENTATION 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONS COVERED
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
    1.6 LIMITATIONS 
    1.7 STAKEHOLDERS 
    1.8 SUMMARY OF CHANGES 
    1.9 RECESSION IMPACT 
2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH APPROACH 
          FIGURE 1 CONTRAST ENHANCED ULTRASOUND MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primaries
                                FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 5 MARKET SIZE ESTIMATION FOR CONTRAST ENHANCED ULTRASOUND INDUSTRY: APPROACH 1 (COMPANY REVENUE ESTIMATION)
                                FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF GE HEALTHCARE
                    2.2.1.2 Approach 2: Customer-based market estimation
                                FIGURE 7 BOTTOM-UP APPROACH FOR MARKET SIZE ESTIMATION
                    2.2.1.3 Growth forecast
                    2.2.1.4 CAGR projections
                                FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.3 DATA TRIANGULATION APPROACH 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET ASSUMPTIONS 
    2.5 RISK ASSESSMENT 
           2.5.1 RISK ASSESSMENT ANALYSIS
    2.6 GROWTH RATE ASSUMPTIONS 
    2.7 RECESSION IMPACT ANALYSIS 
3 EXECUTIVE SUMMARY (Page No. - 41)
    FIGURE 10 CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT & SERVICE,  2023 VS. 2028 (USD MILLION)
    FIGURE 11 CONTRAST ENHANCED ULTRASOUND INDUSTRY, BY APPLICATION,  2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY END USER,  2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET: GEOGRAPHIC SNAPSHOT
4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 CONTRAST ENHANCED ULTRASOUND MARKET OVERVIEW 
          FIGURE 14 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
    4.2 EUROPE: MARKET,  BY PRODUCT & SERVICE, 2023 VS. 2028 
          FIGURE 15 CONTRAST AGENTS SEGMENT TO REGISTER HIGHEST CAGR  DURING FORECAST PERIOD
    4.3 NORTH AMERICA: MARKET, BY APPLICATION, 2023 VS. 2028 
          FIGURE 16 THERAPEUTIC APPLICATIONS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 ASIA PACIFIC: MARKET,  BY END USER 
          FIGURE 17 HOSPITALS AND SURGICAL CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.5 MARKET: GEOGRAPHICAL SNAPSHOT 
          FIGURE 18 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 50)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 CONTRAST ENHANCED ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing incidence of chronic diseases
                    5.2.1.2 Rising technological advancements in contrast-enhanced ultrasound systems
                    5.2.1.3 Increasing initiatives for commercialization of diagnostic imaging equipment
           5.2.2 RESTRAINTS
                    5.2.2.1 Risks associated with contrast agents
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging economies
                    5.2.3.2 Increasing establishment of hospitals and diagnostic imaging centers
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of skilled sonographers
                    5.2.4.2 Presence of alternative techniques
    5.3 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 1 CONTRAST ENHANCED ULTRASOUND INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 TRADE ANALYSIS 
          TABLE 2 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 3 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 4 IMPORT DATA FOR CONTRAST AGENTS, BY COUNTRY, 2018–2022 (USD THOUSAND)
          TABLE 5 EXPORT DATA FOR CONTRAST AGENTS, BY COUNTRY, 2018–2022 (USD THOUSAND)
    5.5 PATENT ANALYSIS 
          FIGURE 20 TOP 10 PATENT APPLICANTS (JANUARY 2012–DECEMBER 2022)
    5.6 ECOSYSTEM COVERAGE OF PARENT MARKET 
    5.7 VALUE CHAIN ANALYSIS 
           5.7.1 RESEARCH & DEVELOPMENT
           5.7.2 MANUFACTURING & ASSEMBLY
           5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
                    FIGURE 21 VALUE CHAIN ANALYSIS
    5.8 SUPPLY CHAIN ANALYSIS 
           5.8.1 PROMINENT COMPANIES
           5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
           5.8.3 END USERS
                    FIGURE 22 SUPPLY CHAIN ANALYSIS
    5.9 PRICING TREND ANALYSIS 
          TABLE 6 AVERAGE SELLING PRICE FOR MAJOR CONTRAST-ENHANCED ULTRASOUND EQUIPMENT
    5.10 TECHNOLOGY ANALYSIS 
    5.11 REGULATORY LANDSCAPE 
           5.11.1 NORTH AMERICA
                    5.11.1.1 US
                                 TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
                                 TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.11.1.2 Canada
                                 TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.11.2 EUROPE
           5.11.3 ASIA PACIFIC
                    5.11.3.1 Japan
                                  TABLE 10 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.11.3.2 China
                                 TABLE 11 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.11.3.3 India
    5.12 REIMBURSEMENT SCENARIO 
           TABLE 12 MEDICAL REIMBURSEMENT CODES FOR CONTRAST-ENHANCED ULTRASOUND PROCEDURES
    5.13 CASE STUDIES 
           5.13.1 TECHNICAL CHALLENGES WITH ULTRASOUND SYSTEMS
                     TABLE 13 CASE STUDY 1: IMPROVED SENSITIVITY AND BETTER VISIBILITY OF BLOOD FLOW
    5.14 KEY CONFERENCES AND EVENTS 
           TABLE 14 MARKET: LIST OF MAJOR CONFERENCES AND EVENTS (2023–2024)
6 CONTRAST ENHANCED ULTRASOUND MARKET,  BY PRODUCT & SERVICE (Page No. - 72)
    6.1 INTRODUCTION 
          TABLE 15 CONTRAST ENHANCED ULTRASOUND INDUSTRY, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
    6.2 EQUIPMENT 
           6.2.1 INNOVATIVE PRODUCT LAUNCHES WITH IMPROVED DIAGNOSIS AND REAL-TIME MONITORING ABILITIES TO DRIVE MARKET
                    TABLE 16 MARKET FOR EQUIPMENT, BY REGION,  2021–2028 (USD MILLION)
    6.3 CONTRAST AGENTS 
          TABLE 17 MARKET FOR CONTRAST AGENTS, BY TYPE,  2021–2028 (USD MILLION)
          TABLE 18 MARKET FOR CONTRAST AGENTS, BY REGION, 2021–2028 (USD MILLION)
           6.3.1 MOLECULE-TARGETED MICROBUBBLES
                    6.3.1.1 Rising use in targeted therapies to drive market
                                TABLE 19 MARKET FOR MOLECULE-TARGETED MICROBUBBLES, BY REGION, 2021–2028 (USD MILLION)
           6.3.2 NANOPARTICLE MICROBUBBLES
                    6.3.2.1 Utilization in thermal therapies to fuel market
                                TABLE 20 MARKET FOR NANOPARTICLE MICROBUBBLES,  BY REGION, 2021–2028 (USD MILLION)
    6.4 SOFTWARE AND SERVICES 
           6.4.1 RISING UTILIZATION OF SOFTWARE FOR OPTIMAL IMAGE VISUALIZATION TO DRIVE MARKET
                   TABLE 21 MARKET FOR SOFTWARE AND SERVICES,  BY REGION, 2021–2028 (USD MILLION)
7 CONTRAST ENHANCED ULTRASOUND MARKET, BY APPLICATION (Page No. - 79)
    7.1 INTRODUCTION 
          TABLE 22 CONTRAST ENHANCED ULTRASOUND INDUSTRY, BY APPLICATION,  2021–2028 (USD MILLION)
    7.2 DIAGNOSTIC APPLICATIONS 
          TABLE 23 MARKET FOR DIAGNOSTIC APPLICATIONS,  BY TYPE, 2021–2028 (USD MILLION)
           7.2.1 CARDIOLOGY
                    7.2.1.1 Increasing incidence of CVD to drive market
                                TABLE 24 MARKET FOR DIAGNOSTIC CARDIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
           7.2.2 HEPATIC
                    7.2.2.1 Utilization of CEUS technology in characterization of focal liver lesions to drive market
                                TABLE 25 MARKET FOR DIAGNOSTIC HEPATIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
           7.2.3 NEPHROLOGY
                    7.2.3.1 Ability to identify renal complications to propel market
                                TABLE 26 MARKET FOR DIAGNOSTIC NEPHROLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
           7.2.4 OTHER DIAGNOSTIC APPLICATIONS
                    TABLE 27 MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
    7.3 THERAPEUTIC APPLICATIONS 
          TABLE 28 MARKET FOR THERAPEUTIC APPLICATIONS,  BY TYPE, 2021–2028 (USD MILLION)
           7.3.1 CARDIOLOGY
                    7.3.1.1 Growing applications in targeted drug delivery to propel market
                                TABLE 29 MARKET FOR THERAPEUTIC CARDIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
           7.3.2 VASCULAR
                    7.3.2.1 Growing use of contrast agents in blood flow dynamics to fuel market
                                TABLE 30 MARKET FOR THERAPEUTIC VASCULAR APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
           7.3.3 ONCOLOGY
                    7.3.3.1 Rising utilization in targeted therapy to drive market
                                TABLE 31 MARKET FOR THERAPEUTIC ONCOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
           7.3.4 OTHER THERAPEUTIC APPLICATIONS
                    TABLE 32 MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
8 CONTRAST ENHANCED ULTRASOUND MARKET, BY END USER (Page No. - 88)
    8.1 INTRODUCTION 
          TABLE 33 CONTRAST ENHANCED ULTRASOUND INDUSTRY, BY END USER,  2021–2028 (USD MILLION)
    8.2 HOSPITALS AND SURGICAL CENTERS 
           8.2.1 RISING NUMBER OF CEUS-BASED MEDICAL PROCEDURES TO DRIVE MARKET
                    TABLE 34 MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION)
    8.3 DIAGNOSTIC IMAGING CENTERS 
           8.3.1 RISING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
                    TABLE 35 MARKET FOR DIAGNOSTIC IMAGING CENTERS,  BY REGION, 2021–2028 (USD MILLION)
    8.4 AMBULATORY SURGERY CENTERS 
           8.4.1 RISING VOLUME OF EMERGENCY SURGERIES TO PROPEL MARKET
                    TABLE 36 MARKET FOR AMBULATORY SURGERY CENTERS,  BY REGION, 2021–2028 (USD MILLION)
    8.5 OTHER END USERS 
          TABLE 37 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
9 CONTRAST ENHANCED ULTRASOUND MARKET, BY REGION (Page No. - 93)
    9.1 INTRODUCTION 
          TABLE 38 CONTRAST ENHANCED ULTRASOUND INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 23 NORTH AMERICA: MARKET SNAPSHOT
           9.2.1 NORTH AMERICA: RECESSION IMPACT
                    TABLE 39 NORTH AMERICA: MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 40 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                    TABLE 41 NORTH AMERICA: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 42 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 43 NORTH AMERICA: MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 44 NORTH AMERICA: MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 45 NORTH AMERICA: MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.2.2 US
                    9.2.2.1 High adoption rate of innovative medical technologies to drive market
                                TABLE 46 US: CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT,  2021–2028 (USD MILLION)
                                TABLE 47 US: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
           9.2.3 CANADA
                    9.2.3.1 Increasing incidence of heart & kidney diseases to drive market
                                TABLE 48 CANADA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                TABLE 49 CANADA: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
    9.3 EUROPE 
           9.3.1 EUROPE: RECESSION IMPACT
                    TABLE 50 EUROPE: CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 51 EUROPE: MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                    TABLE 52 EUROPE: MARKET FOR CONTRAST AGENTS,  BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 53 EUROPE: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 54 EUROPE: MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 55 EUROPE: MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 56 EUROPE: MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.3.2 GERMANY
                    9.3.2.1 High healthcare expenditure to propel market
                                TABLE 57 GERMANY: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                TABLE 58 GERMANY: MARKET FOR CONTRAST AGENTS,  BY TYPE, 2021–2028 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Rising target patient population and government-funded investments for advanced medical equipment to fuel uptake
                                TABLE 59 FRANCE: CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                                TABLE 60 FRANCE: CONTRAST ENHANCED ULTRASOUND INDUSTRY FOR CONTRAST AGENTS,  BY TYPE, 2021–2028 (USD MILLION)
           9.3.4 UK
                    9.3.4.1 Increasing investments in diagnostic imaging to drive market
                                TABLE 61 UK: MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                TABLE 62 UK: CONTRAST-ENHANCED ULTRASOUND FOR CONTRAST AGENTS, BY TYPE,  2021–2028 (USD MILLION)
           9.3.5 REST OF EUROPE
                    TABLE 63 REST OF EUROPE: CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                    TABLE 64 REST OF EUROPE: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
    9.4 ASIA PACIFIC 
           FIGURE 24 ASIA PACIFIC: MARKET SNAPSHOT
           9.4.1 ASIA PACIFIC: RECESSION IMPACT
                    TABLE 65 ASIA PACIFIC: MARKET, BY COUNTRY,  2021–2028 (USD MILLION)
                    TABLE 66 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                    TABLE 67 ASIA PACIFIC: MARKET FOR CONTRAST AGENTS,  BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 68 ASIA PACIFIC: MARKET, BY APPLICATION,  2021–2028 (USD MILLION)
                    TABLE 69 ASIA PACIFIC: MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 70 ASIA PACIFIC: MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 71 ASIA PACIFIC: MARKET, BY END USER,  2021–2028 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Presence of universal healthcare reimbursement system to support market growth
                                TABLE 72 JAPAN: CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT &  SERVICE, 2021–2028 (USD MILLION)
                                TABLE 73 JAPAN: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
           9.4.3 CHINA
                    9.4.3.1 Rising government initiatives for improvements in healthcare infrastructure to drive market
                                TABLE 74 CHINA: MARKET, BY PRODUCT &  SERVICE, 2021–2028 (USD MILLION)
                                TABLE 75 CHINA: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Growing public-private investments in novel medical technologies to drive market
                                TABLE 76 INDIA: CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)
                                TABLE 77 INDIA: CONTRAST ENHANCED ULTRASOUND INDUSTRY FOR CONTRAST AGENTS,  BY TYPE, 2021–2028 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 78 REST OF ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                    TABLE 79 REST OF ASIA PACIFIC: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
    9.5 REST OF THE WORLD 
           9.5.1 REST OF THE WORLD: RECESSION IMPACT
                    TABLE 80 REST OF THE WORLD: CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
                    TABLE 81 REST OF THE WORLD: MARKET FOR CONTRAST AGENTS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 82 REST OF THE WORLD: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 83 REST OF THE WORLD: MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 84 REST OF THE WORLD: MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 85 REST OF THE WORLD: MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 122)
     10.1 OVERVIEW 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 25 CONTRAST ENHANCED ULTRASOUND MARKET: KEY PLAYER STRATEGIES
     10.3 REVENUE SHARE ANALYSIS 
             FIGURE 26 CONTRAST ENHANCED ULTRASOUND INDUSTRY: REVENUE SHARE ANALYSIS OF LEADING PLAYERS (2022)
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 27 MARKET: MARKET SHARE ANALYSIS OF LEADING PLAYERS (2022)
             TABLE 86 MARKET: INTENSITY OF COMPETITIVE RIVALRY
     10.5 COMPANY EVALUATION MATRIX (2022) 
             10.5.1 STARS
             10.5.2 PERVASIVE PLAYERS
             10.5.3 EMERGING LEADERS
             10.5.4 PARTICIPANTS
                        FIGURE 28 MARKET: COMPANY EVALUATION MATRIX (2022)
     10.6 COMPETITIVE BENCHMARKING 
             TABLE 87 MARKET: PRODUCT & REGIONAL FOOTPRINT ANALYSIS
     10.7 COMPETITIVE SCENARIO AND TRENDS 
             10.7.1 PRODUCT LAUNCHES
                        TABLE 88 MARKET: PRODUCT LAUNCHES  (JANUARY 2020–JULY 2023)
             10.7.2 DEALS
                        TABLE 89 MARKET: DEALS (JANUARY 2020–JULY 2023)
             10.7.3 OTHER DEVELOPMENTS
                        TABLE 90 MARKET: OTHER DEVELOPMENTS (JANUARY 2020−JULY 2023)
11 COMPANY PROFILES (Page No. - 131)
     11.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 GE HEALTHCARE
                        TABLE 91 GE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 29 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
             11.1.2 LANTHEUS
                        TABLE 92 LANTHEUS: COMPANY OVERVIEW
                        FIGURE 30 LANTHEUS: COMPANY SNAPSHOT (2022)
             11.1.3 BRACCO IMAGING S.P.A.
                        TABLE 93 BRACC0 IMAGING S.P.A.: COMPANY OVERVIEW
             11.1.4 KONINKLIJKE PHILIPS N.V.
                        TABLE 94 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
             11.1.5 SIEMENS HEALTHINEERS
                        TABLE 95 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
                        FIGURE 32 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
             11.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
                        TABLE 96 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
                        FIGURE 33 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2022)
             11.1.7 CANON INC.
                        TABLE 97 CANON INC.: COMPANY OVERVIEW
                        FIGURE 34 CANON INC.: COMPANY SNAPSHOT (2022)
             11.1.8 ESAOTE S.P.A
                        TABLE 98 ESAOTE S.P.A: COMPANY OVERVIEW
             11.1.9 SAMSUNG ELECTRONICS CO., LTD.
                        TABLE 99 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW
                        FIGURE 35 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2022)
             11.1.10 GUERBET
                        TABLE 100 GUERBET: COMPANY OVERVIEW
                        FIGURE 36 GUERBET: COMPANY SNAPSHOT (2022)
     11.2 OTHER PLAYERS 
             11.2.1 NANOPET PHARMA GMBH
             11.2.2 BAYER AG
             11.2.3 REVVITY
             11.2.4 SOLSTICE PHARMACEUTICALS B.V.
             11.2.5 TRIVITRON HEALTHCARE
             11.2.6 LERIVA
             11.2.7 JB PHARMA
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 167)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS